FDA to discuss Abbott's Humira for UC

14:21 EDT 21 Jun 2012 | BioCentury

FDA's Gastrointestinal Drugs Advisory Committee will meet on Aug. 28 to discuss an sBLA from Abbott Laboratories (NYSE:ABT) for Humira adalimumab to treat moderately to severely active ulcerative colitis in adults who failed conventional therapies. T..

Original Article: FDA to discuss Abbott's Humira for UC

More From BioPortfolio on "FDA to discuss Abbott's Humira for UC"

Biotech & Healthcare Channels World News Life Science Events Corporate Database Market Reports Categories

Search BioPortfolio:

Clinical Trials - Daily Updated Database search the latest medical and pharmaceutical trials.

Drugs Database search our comprehensive database of prescription drugs.

Research Literature - Daily Updated Database search biomedical papers and journals.

News Quicklinks

Search Biotech, Medical and Healthcare News

Biotech News by Article Type

Biotech News by Location

BioPortfolio Bloggers

Publishing Your News on BioPortfolio

Recent Visitor News Searches

Searches Linking to this Story

Humira UC FDA, Humira UC FDA, humira for uc, fda to discuss abbott's humira for uc, humira ulcerative colitis advisory committee FDA, humira ulcerative colitis advisory committee FDA, humira ulcerative colitis advisory committee FDA, humira ulcerative colitis advisory committee FDA, humira us approval update for uc, abbott humira advisory committee, Abbott resubmits sBLA for humira in UC, fda adcom on humira uc, fda adcom on humira uc, humira uc fda update, humira uc adcom

Latest Biotechnology, Pharmaceutical and Healthcare News

How To Stop Drafts and Save On Home Energy Bills This Summer - New Draft Stoppers Now Available From Battic Door Energy Conservation

Age Brings Happiness

Slow Healing: Cell Therapy in the US Industry Market Research Report Now Available from IBISWorld

Criminal Attorneys Provide Memorial Day Weekend DUI Checklist and Safety Information

Men With Afflicted Illnesses Must Know What to Expect from Prostate Surgeries while Dr. Allen’s Device Reverses BPH Naturally, Highlights Fine Treatment

TheBeautyPlace.com Debuts Their Brand New Beauty Kits

Dr. Leslie Gerstman Is Now Offering the Non-surgical Facelifting Procedure â Ultherapy â in NYC and NJ

BioPortfolio Limited

Publish Content

Agreements

Tools

Help

This site complies with the HONcode standard for trustworthy health information:
Verify here.

The information provided by BioPortfolio.com is not a substitute for professional medical advice, diagnosis or treatment. The BioPortfolio site is sponsored BioPortfolio Limited with offices at Stafford House, 10 Prince of Wales Road, Dorchester, DT1 1PW, England. If you are a legal copyright holder or a designated agent for such and you believe a post on this website falls outside the boundaries of “Fair Use” and legitimately infringes on your or your client's copyright we may be contacted concerning copyright matters at: priority@bioportfolio.com.
All rights reserved. All other trademarks recognized. Copyright © 1997-2013 BioPortfolio Limited. Site developed by Alacrify Ltd.